廖啟成,(1998),乳酸菌之分類利用,食品工業30: 1-10。
廖啟成,(1998),乳酸菌之分類利用,食品工業,第30期第1-10頁。
劉嚞睿,林慶文。(2002)。黃豆之機能活性。科學農業50:194-201。
林慶文。(1996),乳品加工學,第11-23 頁及第522 頁,華香園出版社,台北。
高唯敏,(2007),乳酸菌菌粉之賦形劑配方與乾燥條件對菌體活性之影響,朝陽科技大學生物技術研究所碩士論文,台中。黃則棓,(2005)「乳酸菌粉劑試量產-菌種及培養基之探討」,碩士論文,朝陽科技大學應用化學系(所),台中。江柏源,陳文騰。(1999)。天然、完美、營養的泉源~黃豆(上)。農業世界雜誌191:78-81。
蕭如吟,(2002),利用單獨及混合乳酸菌試製羊乳酸凝酪之研究,東海大學食品科學系研究所碩士論文,台中,台灣。謝孟荔,(2004),乳酸菌與雙叉桿菌發酵豆奶之抗致突變性,臺灣大學食品科技研究所碩士論文,台北。鄭安平,(2002),攝食益生菌奶粉對健康成人腸道菌相之影響,臺灣大學食品科技研究所博士論文,台北。張世明。(1992)。黃豆蛋白食品之最新發展。食品工業24:50-56。程金燕,(2000),由改善腸胃道的功能來探討機能性食品的功效。食品工業,32(6):48-57。陳炎祥,(2004),提升免疫力的乳酸菌,科技發展,373,34-37。
陳世爵。(1986)。豆乳製造原理。食品工業18(10):10-24。
程金燕,(2000),由改善腸胃道的功能來探討機能性食品的功效。食品工業,32(6):48-57。施宗雄,(1998) ,台灣乳酸菌類研究之介紹及在飼料添加劑上之應用,生物產業 Bioindustry 9(4):17-21,。蔡佳原。(2001)。黃豆機能性成分其加工利用。食品市場資訊90:7-11。蔡英傑,(1998),乳酸菌應用綜論,生物產業,9 (4):258-264。王舒徽,(2000),原生菌之機能性介紹,食品工業,32:741-51。王宜婕,(2004),乳酸菌與雙叉桿菌發酵豆奶及其產品之抗氧化活性,臺灣大學食品科技研究所博士論文,台北。Arunachalam KD. (1999) “Role of bifidobacteria in nutrition,” Medicine and Technology Nutr. Res,Vol. 19, pp. 1559-1597.
Bernet MF., Brassart D., Neeser JR., Servin AL. (1993) “Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions,” Appl. Environ Microbiol, Vol. 59, pp. 4121-4141.
Buono M. A., Setser C., Erickson L. E. and Fung D. Y. C.(1990).Soymilk yogurt:sensory evaluation and chemical measurment. J. Food Sci. 55:528-531.
Collins JK, Thornton G, Sullivan GO. (1998) “Selection of probiotic strains for human applications,” Int Dairy J, Vol. 8, pp. 487-490.
De Varies W and Stouthamer AH. (1997) “Pathway of glucose fermentation in relationto taxonomy of bifidobacteria,” J. Bacteriol, Vol. 93, pp. 574-576.
Frazier WC., Westhoff DC. (1988). Microorganisms important in food microbiology.(In: Frazier WC., Westhoff DC., eds. Food Microbiology. 4th edn.),McGraw-Hill Book Co, New York, pp. 35-97.
Fukushima D.(1991). Recent progress of soybean protein foods: foods, chemistry, technology and nutrition. Food Rev. Int. 7:323-351.
Ferrari, A., Pacini, N. and Canzi, E.(1980). A note on bile acids transformations by strains of Bifidobacterium. J. Appl. Bacteriol., 49: 193-197.
Gomes AMP, Malcata FX. (1999). “Bifidobacterium spp. and Lactobacillus acidophilus: biological, biochemical, technological and therapeutical properties relevant for use as probiotics,” Trend Food Sci Technol, Vol. 1, pp. 139-157.
Hose H., Sozzi T. (1991). “Biotechnology group meeting probiotics - fact or fiction,” J.Chem Technol Biotechnol, Vol. 51, pp. 540-544.
Hosono A., Lee J., Ametani A., Natsume M., Hiratama M., Adachi T. and Kaminogawa S.(1997). “Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4,” Biosci Biotech Biochem, Vol. 61, No. 2, pp.312-316.
Jao, YC., Mikolajcik EM., Hansen, PMT. (1978). “Growth of Bifidobacterium bifidumvar. pennsylvanicus in laboratory media supplemented with amino sugars and spent broth from Escherichia coli,” J. Food Sci, Vol. 43, pp.1257-1260, 1263.
Kaur, I. P., K. Chopra, and A. Saini, (2002) “Probiotics: potential pharmaceuticalapplications,” Eur. J. Pharm. Sci, Vol. 15, pp. 1-9.
Klaenhammer, T. R. and M. J. Kullen, (1999) “Selection and design of probiotics,” Int.J. Food Microbiol, Vol. 50, pp. 45-57. Lee S-Y., Morr C. V. and Seo A.(1990). Comparison of milk-based and soymilk-based yogurt. J. Food Sci. 55:532-536.
Mrda Z, Zivanović M, Rasić J, Gajin S, Somer L, Trbojević S, Majoros J, Petrović Z.;(1998);Therapy of Helicobacter pylori infection using Lactobacillus acidophilus;Med Pregl.(1998)Jul-Aug;51(7-8)343-5.
Marteau., P., Pochart., P., Flourié., B., Pellier., P., Santos., L., Desjeux., J.,F., Rambaud., J.,C., (1990) ; Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans., Am J Clin Nutr.;52(4):685-8.
Mary E., S., ;(2000); Considerations for Use of Probiotic Bacteria to Modulate Human Health., J. Nutr. 130: 384S–390S.
Marin., M., L., Tejada-Simon, M., V… Lee., J., H., Murtha, J., Ustunol., Z., Pestka., J., J.. (1998); Stimulation of Cytokine Production in Clonal Macrophage and T-Cell Models by Streptococcus thermophilus: Comparison with Bifidobacterium sp. and Lactobacillus bulgaricus ., Journal of Food Protection, Volume 61, Number 7, pp. 859-864
Motlagh, A. M., S. Holla, M. C. Johnson, B. Ray and R. A. Field, (1992) “Inhibition ofListeria spp. in sterile food systems by pediocin AcH, a bacteriocinproduced by Pediococcus acidilactici H,” J. Food Prot, Vol. 55, pp.337-343.
Murti T. W., Bouillanne C., Landon M.and Desmazeaud M. J. (1992).Bacterial growth and volatile compounds in yoghurt-type products form soymilk containing Bifidobacterium ssp. J. Food Sci. 00:153-156.Morotomi, M. and Mutai, M. (1986). In vitro binding of potent mutagenic pyrolysates by intestinal bacteria. J. Natl. Cancer Inst., 77: 195-201.
Nicole M de R.,and Martijn B K.,(2000 ); Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a review of papers published between (1988) and (1998)., Am J Clin Nutr ;71:405–11.
Naidu AS., Bidlack WR., Clemens RA. (1999) .“Probiotic spectra of lactic acid bacteria,” Food Sci Nutr., Vol. 38, pp. 13-126.
Norris RF., Flanders T., Tomarelli RM., Gyorgy P. (1950). “The isolation and cultivation of Lactobacillus bifidus: a comparison of branched and unbranched strains,” J. Bacteriol, Vol. 60, pp. 49-50.
O''Sullivan MG., Thornton G., O''Sullivan GC., Collins JK.(1992) “Probiotic bacteria:Myth or reality” Trends Food Sci Technol, Vol. 3, pp. 309-314.
Ozaki Y. (1991). “The promotion of growth of Bifidobacteria with various Kinds of sugars,” New Food Ind., Vol. 32, pp. 12-15.
Orrhage K, Sillerström E, Gustafsson JÅ, Nord CE and Rafter J.(1994). Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mutat Res 311:239-248.
Parvez, S., Malik, K.A., Kang, S.A. and Kim, H.Y. (2006). Probiotics and their fermented food products are beneficial for health. Journal of Applied Microbiology 100: 1171-1185.
Reddy,B., and Rivenson,A.(1993). “Inhibitory effect of Bifidobacterium longum oncolon, mammary, and liver carcinogensis induces by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen,”Cancer Res.,Vol. 53, pp. 3914-3918.
Ramakrishna, Y., Singh, R. S. and Anand, S. K.(1985). ”Effect of streptomycin on lactic cultures,” Cult. Dairy Prod. J., Vol. 20, pp. 12-13.
Sanders* M. E., Klaenhammer T. R.,;(2001);Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic;J. Dairy Sci. 84:319–331
Saavedra., J., M,, Bauman., N., A,, Oung., I., Perman., J.,A,, Yolken., R., H.,.(1994); Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus . The Lancet , Volume 344 , Issue 8929 , Pages 1046 – 1049.
Sanders ME. (1998). “Overview of functional foods: emphasis on probiotic bacteria,”Int. Dairy J., Vol. 8, pp. 341-347.
Setchell K. D. R. and Cassidy A. (1999). Dietary isoflavones: biological effects and relevance to human health. J. Nutr. 129:758s-767s.
Sreekumar, O. and Hosono, A. (1998). Antimutagenicity and influence of physical factors in binding Lactobacillus gasseris and Bifidobacterium longum cells to amino acid pyrolysates. J. Dairy Sci., 81: 1508-1516.
Sekine,K., Ohta,J., Onishi,M., Tatsuki,T., Shimokawa,Y., Toida,T., Kawashima,T., and Hashimoto,Y.(1995). Analysis of antitumor properties of effector cells stimulated with a cell wall prepartion (WPG) of Bifidobacterium infantis. Biol.Pharm.Bull., 18:148-153
Thananunkul D., Tanaka M., Chichester C. O. and Lee T. C. (1976). Degradation of raffinose and stachyose in soybean milk by a-galactosidase from Moritierella vinacea. Entrapment of a-galactosidase within polyacrylamide gel. J. Food Sci.41:173-175.
Tsangalis D.,Ashton J. F., Mcgill A. E. J. and Shah N.P.(2002). Enzymetic transformation of isoflavone phytoestrogens in soymilk by b-glucosidase-producing bifidobacteria. J. Food Sci. 67:3104-3113.
Takahashi,T., Oka,T., Iwana,H., Kuwata,T., and Yamamoto,Y. (1993). mmune response of mice to orally administered lactic acid bacteria. Biosci. Biotech. Biochem., 57:1557-1560.
Van der Schouw Y. T., de Kleijn M. J., Peeters P. H. and Grobbee D. E. (2000). Phyto-estrogens and cardiovascular disease risk. Nutr. Metab. Cardiov. Dis. 10:154-167.
Yasui, H., and Ohwaki, M. (1991). “Enhancement of immune response in Peyer’s patchcells cultured with Bifidobacterium breve,” J.Dairy Sci., Vol. 74, pp. 1187-1195.
Zhang, X. B. and Ohta, Y.(1993). Antimutagenicity of cell fractions of microorganisms on potent mutagenic pyrolysates. Mutat. Res., 298: 247-253.
Zhang, X. B. and Ohta, Y.(1991). Binding of mutagens by fractions of the cell wall skeleton of lactic acid bacteria on mutagens. J. Dairy Sci., 74: 1477-1481.